Core Viewpoint - The establishment of the "De Yi Traditional Chinese Medicine Innovation and Transformation Center" marks a significant step in Shenzhen's efforts to develop a leading TCM innovation city and a strategic platform for the inheritance and innovation of TCM in the Guangdong-Hong Kong-Macao Greater Bay Area [1][2]. Group 1: Challenges and Objectives - The TCM sector faces challenges such as insufficient inheritance, lack of innovation, and ineffective transformation mechanisms [2]. - Shenzhen, despite its advantages, still lags behind cities like Beijing and Shanghai in TCM innovation and patent output [2]. - The center aims to leverage the unique policies and advantages of the He Tao Cooperation Zone to explore new paths for TCM modernization, industrialization, and internationalization [2]. Group 2: Development Framework - The center's construction is a systematic restructuring rather than mere spatial expansion, with a clear top-level design [3]. - It establishes a "one-three-five-seven" development system, focusing on creating an international TCM innovation transformation platform [3]. - The three platforms include a TCM health product drug transformation platform, an intelligent TCM equipment system platform, and a Hong Kong-Shenzhen TCM cooperation exchange platform [3]. Group 3: Core Advantages and Focus Areas - The center will focus on major chronic diseases such as cardiovascular diseases, diabetes, tumors, and respiratory diseases, utilizing the clinical foundation of Guangzhou University of Chinese Medicine Shenzhen Hospital [4]. - It aims to enhance technology research and product innovation through multi-party collaboration and complementary advantages [4]. Group 4: Systematic Support and International Collaboration - The center will establish a comprehensive support system from laboratory to market, including a professional concept verification and small-scale testing base [5]. - A technical transfer team will provide one-stop services covering intellectual property, outcome evaluation, and commercial connections [5]. - The center will promote AI technology integration and international collaboration, connecting global resources to advance TCM innovation [5]. Group 5: Collaborative Mechanisms and New Business Models - The center will promote cross-border joint research mechanisms and resource sharing among universities, research institutions, and enterprises in the Greater Bay Area [6]. - It will explore new business models combining TCM, health care, and tourism, developing cross-border health tourism products [7]. Group 6: Initial Achievements and Future Outlook - The center has already made progress in areas such as in-hospital formulation development, intelligent TCM equipment research, and patent transformation [8]. - It has signed cooperation agreements with over 20 domestic and international institutions and enterprises, establishing a diversified ecosystem for industry-university-research collaboration [8]. - The center aims to build a national-level TCM inheritance and innovation center, creating a virtuous cycle of research, transformation, industry, and promotion [8].

独家深度推荐： 药明康德上市以来股东累套现400亿 实控人方大举套现百亿引市场警惕 北斗院二次"冲A"17家机构突击入股 手握4.59亿现金募资7亿必要性存疑 魏应州家族缔造686亿快消巨头 康师傅两大业务下滑 魏宏丞接棒临挑战 三六零否认财务造假市值两天蒸发65亿 近四年累亏39亿仍分红21亿遭质疑 沐曦股份首日涨近7倍 葛卫东12.5亿重仓押注暴赚211亿 同仁堂卷入磷虾油造假风波陷信任危机 市值450亿不及云南白药一半 纳百川依赖"宁王"毛利率四连降 经营现金流告负货币资金仅1.88亿 东莞银行A股候场17年无果 两年被罚1332万董监高涨薪225万 林清轩三年半砸11亿营销为研发12倍 多次虚假宣传被罚 信邦制药涉单位行贿被起诉 股价两跌停业绩萎靡 陈景河32年全球狂购缔造万亿矿业帝国 紫金矿业有息负债1696亿 天风证券或涉当代集团违规占资被立案 前三季盈利1.53亿 碧桂园前11月交付14万套 境内外债务重组落地有望化债超900亿 广州农商行三年剥离481亿债权减压 半年贷款减值损失31亿 ...

12月23日，微信官方辟谣平台"谣言过滤器"微信公号发布消息，全文如下： 12月22日晚某直播平台遭到黑灰产攻击，部分传言称"违规直播间中隐藏着病毒链接，许多用户点入后，微信账号即被盗取，不法分子随即向账号好友发 送借款请求，实施诈骗。" 经核实，上述信息不属实。微信账号有严格的安全保护机制，截至目前，我们没有发现相关问题和收到类似反馈。 请大家不要轻易点击可疑链接，若不小心点击了，切记不要输入或透露个人密码与手机验证码，切实提高安全意识。 来源：第一财经微信公众号 关注" 新华网财经 "视频号 更多财经资讯等你来看 往期推荐 罗永浩吐槽"宽带缩水"，上海电信回应 同仁堂致歉 ...

Group 1 - The core activity is a series of public welfare events initiated by Tongrentang Technology Company and Beijing Youth Daily, focusing on integrating traditional Chinese medicine (TCM) culture into rural revitalization efforts [1][21] - The events include winter health consultations and TCM cultural experience activities, aimed at promoting health and wellness through TCM knowledge [1][10] - The activities are designed to be engaging and educational, featuring hands-on experiences such as making traditional Chinese medicine pills and learning about herbal identification [3][5] Group 2 - In the community, TCM lectures cover winter health tips, dietary recommendations, and acupoint massage techniques, helping residents understand TCM practices [12][14] - The events also include interactive experiences, such as creating aromatic bracelets, which enhance community engagement with TCM culture [15] - Health consultations provided by experts from Tongrentang and Beijing University of Chinese Medicine address residents' health concerns, offering personalized advice and treatments [17][19] Group 3 - A separate initiative focuses on children with autism, providing TCM cultural experiences and health consultations tailored to their needs [21][23] - The program includes donations of essential rehabilitation materials and aims to improve the well-being of special needs children through TCM therapies [21][23] - The immersive activities allow participants to experience TCM culture through multiple senses, fostering a deeper appreciation for its benefits [23]

往期推荐 同仁堂致歉 美国纽约商品交易所黄金期货价格22日盘中突破每盎司4500美元，创历史新高。 来源：新华社 关注" 新华网财经 "视频号 更多财经资讯等你来看 罗永浩吐槽"宽带缩水"，上海电信回应 ...

在北京国家大剧院的演出，更能"隔空"被全国观众同步欣赏。"国家大剧院'第二现场'已成为国内迄今为 止覆盖区域最广、联动影剧院最多、协作技术环节最复杂的演出直播活动。"国家大剧院党组成员、副 院长马荣国介绍，该项目不仅将剧场"搬"到屏幕上，还将落地马来西亚，成为中国文化"走出去"的数字 化新实践。 体育赛事赋能城市发展的探索也在持续。北京中国网球公开赛体育推广有限公司副总经理周博带来了一 组数据：2025年中网赛事期间，共有36万人次游客进入国家网球中心；今年中网各方面收入总额同比增 长12%，带动赛期综合消费3611万元。 2026年，北京文商旅体展融合将更上一层楼。市商务局二级巡视员卢跃介绍，北京已获批开展新业态新 模式新场景"三新"试点及国际化消费环境建设试点。下一步，北京将健全首发经济服务体系、创新多元 化服务消费场景、支持优质消费资源与知名IP跨界联名，同时支持打造国际消费集聚区及入境友好型商 圈、支持离境退税商店集聚发展、支持发展"即买即退"退税便利服务等。 多业态融合燃动城市发展新引擎。昨天，由北京日报社主办的2025文商旅体展融合发展共创会圆满落 幕。共创会以"文商旅体展 融出新京彩"为主题，相 ...

Core Insights - The integration of digital transformation and the "Healthy China" strategy has elevated corporate health management from a traditional welfare option to a critical variable for organizational resilience and growth certainty [1] - JD Health is emerging as a core driver in the rapidly growing market, leveraging its unique advantages such as a vast customer base and comprehensive health service capabilities [1][3] - The establishment of the "2026 Billion Brand Alliance" aims to enhance collaboration and accelerate market penetration for partner brands in the corporate health sector [6] Market Dynamics - The corporate health consumption market is experiencing explosive growth driven by policy support, corporate demands, and heightened employee health awareness [1] - JD Health's enterprise business has seen significant performance, with over 800 partner brands and a notable number achieving sales in the millions [3] Strategic Development - JD Health has outlined three core development directions for 2026: solidifying product and supply chain foundations, scaling centralized procurement models, and strategically investing in corporate medical funds [1][6] - The company is transitioning from a "behind-the-scenes supplier" to a "direct service provider" in the medical fund sector, which has shown nearly 100% growth in 2025 [8][9] Service Innovation - JD Health is focusing on creating a comprehensive health service ecosystem that integrates various health management scenarios, including emergency response and chronic disease management [4][5] - The company is enhancing its digital capabilities through AI tools to provide precise service matching and improve the overall employee health management experience [4][6] Competitive Advantages - JD Health's competitive edge lies in its robust supply chain, strong service capabilities, and deep integration of digital tools, which collectively enhance its market position [3][4] - The company is committed to transforming employee health management into a core driver of organizational productivity and high-quality development [2][10]

中国商报（记者 蒋永霞）初冬的延庆，长城脚下银装素裹，世园公园静谧悠然，滑雪场人声鼎沸。作为首都生态涵养区，延庆正以一场由政策驱动、场景 牵引、产业融合的消费变革，悄然重塑区域商业格局。 北京市延庆区商务局党组书记、局长张文静。中国商报记者彭婷婷/摄 12月18日，在第十二届中国商业创新大会上，北京市延庆区商务局党组书记、局长张文静接受了中国商报记者的专访。在采访中，她详细阐述了延庆区在释 放消费活力、推动商业创新方面的思考与实践。 4000万元真金白银力推"五业融合" "我们坚持主动创新，多措并举释放区域消费活力。首要举措是创新政策供给。"张文静开门见山。今年以来，延庆区商务局率先发布文旅体商农融合发展促 消费政策，计划两年统筹财政资金4000万元，围绕新活动、新赛事、新场景、新业态、新产品等12个方向精准施策。 这一政策已迅速落地见效。截至目前，已有15家企业获得首批政策奖励581万元，直接带动消费近2.5亿元。政策的"杠杆效应"初步显现。 延庆区发布文旅体商农融合发展促消费政策，统筹财政资金4000万元，围绕12个方向精准施策。 张文静强调，融合发展并非简单叠加，而是通过顶层政策设计提供"燃料"，引导文 ...

同仁堂致歉 罗永浩吐槽"宽带缩水"，上海电信回应 中国人民银行授权全国银行间同业拆借中心公布，2025年12月22日贷款市场报价利率（LPR）为：1年期LPR为3.0%，5年期以上LPR为3.5%；两者均维持 不变。以上LPR在下一次发布LPR之前有效。 来源：央行网站 关注" 新华网财经 "视频号 更多财经资讯等你来看 往期推荐 ...

及其对照指纹图谱（ R ） 图15 批加味逍遥丸指纹图谱 维度升级：本项目研究将质量监控从单一指标升级为覆盖全方君臣佐使的"功效成分群"定量模式，来源 于君药（柴胡）、臣药（牡丹皮、栀子）及佐使药（白芍、甘草）的八种测定成分经证实与加味逍遥丸 疏肝清热等核心功效直接相关，标志着质量控制从"成分检测"迈向"功效关联"的科学新阶段。 近日，由同仁堂与北京中医药大学联合开展的加味逍遥丸质量评价研究取得重要成果。相关论文已在中 文核心期刊《西北药学杂志》正式收录，该项研究创新构建了"双维度指纹图谱-功效成分定量"质控新 模式，有效破解了中药复方多类型成分、尤其是弱紫外吸收核心成分同步检测的技术难题。 此项研究是同仁堂"守正创新"的典范，通过科技创新为百年古方注入现代科学内涵。新方法将为产品的 安全、有效与优质稳定提供更强技术保障，也为中药行业复方制剂的精准质控提供了创新性的"同仁堂 方案"。同仁堂将继续以科技赋能传统，以品质守护健康，助力中药产业高质量发展。 方法首创：成功利用HPLC-PDA-ELSD双检测器联用技术，首次实现对加味逍遥丸中紫外强吸收成分 （如栀子苷）与弱紫外吸收核心功效成分（如柴胡皂苷A、D）的同 ...